Page last updated: 2024-08-21

thiazoles and EBV Infections

thiazoles has been researched along with EBV Infections in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dreyfus, DH; Faggioni, A; Farina, A; Farina, GA; Lacconi, V; Lenna, S; Morrone, S; Peruzzi, G; Quarta, S; Rosato, E; Trojanowska, M; Vestri, AR; York, M	1
Donovan, J; Huang, D; Li, JH; Liu, FF; Weinrib, L	1

Other Studies

2 other study(ies) available for thiazoles and EBV Infections

Article	Year
Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes. Arthritis research & therapy, 2017, 02-28, Volume: 19, Issue:1 Topics: Adult; Aged; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Epstein-Barr Virus Infections; Female; Gene Expression; Gene Expression Profiling; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Immunity, Innate; Male; Middle Aged; Monocytes; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Scleroderma, Systemic; Thiazoles; Toll-Like Receptor 8; Virus Replication; Young Adult	2017
Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma. Cancer gene therapy, 2001, Volume: 8, Issue:5 Topics: Adenoviridae; Antineoplastic Agents; beta-Galactosidase; Blotting, Western; Cell Survival; Cisplatin; Combined Modality Therapy; Epstein-Barr Virus Infections; Gene Expression; Genetic Therapy; Genetic Vectors; Herpesvirus 4, Human; Humans; Nasopharyngeal Neoplasms; Tetrazolium Salts; Thiazoles; Transfection; Tumor Suppressor Protein p53	2001

Article

Year

Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.

Arthritis research & therapy, 2017, 02-28, Volume: 19, Issue:1

Topics: Adult; Aged; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Epstein-Barr Virus Infections; Female; Gene Expression; Gene Expression Profiling; Herpesvirus 4, Human; Host-Pathogen Interactions; Humans; Immunity, Innate; Male; Middle Aged; Monocytes; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; Scleroderma, Systemic; Thiazoles; Toll-Like Receptor 8; Virus Replication; Young Adult

2017

Cisplatin chemotherapy plus adenoviral p53 gene therapy in EBV-positive and -negative nasopharyngeal carcinoma.

Cancer gene therapy, 2001, Volume: 8, Issue:5

Topics: Adenoviridae; Antineoplastic Agents; beta-Galactosidase; Blotting, Western; Cell Survival; Cisplatin; Combined Modality Therapy; Epstein-Barr Virus Infections; Gene Expression; Genetic Therapy; Genetic Vectors; Herpesvirus 4, Human; Humans; Nasopharyngeal Neoplasms; Tetrazolium Salts; Thiazoles; Transfection; Tumor Suppressor Protein p53

2001